Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes

Iosif Xenogiannis, Ilias Nikolakopoulos, Oleg Krestyaninov

  • 1Minneapolis Heart Institute, 920 E 28th Street #300, Minneapolis, Minnesota 55407 USA. esbrilakis@gmail.com.

Insights

Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) significantly improves angina and reduces major adverse cardiovascular events (MACE). However, CTO-PCI success was not independently linked to MACE in multivariable analysis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • The clinical benefit of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) on angina and major adverse cardiovascular events (MACE) remains debated.
  • Assessing the impact of successful CTO-PCI versus failed procedures is crucial for patient outcomes.

Purpose of the Study:

  • To compare patient-reported angina and MACE incidence between successful and failed CTO-PCI.
  • To evaluate the association between CTO-PCI success and cardiovascular outcomes in a large patient cohort.

Main Methods:

  • A multicenter registry of 1612 patients undergoing CTO-PCI was analyzed.
  • Patient-reported angina and MACE (death, myocardial infarction, target-vessel revascularization) were compared between successful (n=1387) and failed CTO-PCI groups.

Main Results:

  • Successful CTO-PCI was associated with significantly lower rates of prior heart failure, myocardial infarction, and coronary revascularization.
  • Patients with successful CTO-PCI reported greater angina improvement (83% vs 38%) and had lower 1-year MACE incidence (8% vs 15%) compared to failed procedures.
  • Despite univariable associations, CTO-PCI success was not an independent predictor of MACE on multivariable analysis.

Conclusions:

  • Successful CTO-PCI is linked to improved angina and reduced MACE incidence on univariable analysis.
  • The findings highlight the importance of procedural success for symptom relief and short-term event reduction in CTO-PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
169
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
168
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
131
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
282
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
153
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
520